A Republican bill with 1 Democratic cosponsor · See all 2 cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "Dialysis-Related Amyloidosis Treatment Act of 2025," seeks to amend title XVIII of the Social Security Act. It aims to provide coverage and payment under the Medicare program for specific treatments for dialysis-related amyloidosis. These treatments include items or services approved by the Food and Drug Administration and any necessary supplies or services provided adjunct to them. The bill changes how these treatments are classified and paid for within dialysis facilities. The amendments are set to take effect on the date the Act is enacted.
Yes· 3 of 5
- Scored +7
Would people over 65 be better off under this?
Seniors on Medicare are the primary beneficiaries of expanded coverage for dialysis-related amyloidosis.
- Scored +7
Would retired people be better off under this?
Retirees often rely on Medicare and will benefit from coverage for these specific medical treatments.
- Scored +7
Does this make health care easier to get in general?
The bill ensures coverage and separate payment for essential treatments for dialysis-related amyloidosis.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Medicare Coverage: The bill adds "treatments for dialysis-related amyloidosis" to the list of covered items under Section 1861(s)(2) of the Social Security Act, which could provide coverage for items or services furnished in a dialysis facility that are FDA-approved for this condition (Section 2(a)).
-
Guaranteed Payment for Treatments: Under Section 2(c), the bill specifies that payment for these treatments shall be made separately at 100 percent of the reasonable charges for the items and services, rather than including them in standard renal dialysis service payments.
Potential Negative Impacts for People
- No specific negative impacts are mentioned in the text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would retired people be better off under this? — Retirees often rely on Medicare and will benefit from coverage for these specific medical treatments. Would people over 65 be better off under this? — Seniors on Medicare are the primary beneficiaries of expanded coverage for dialysis-related amyloidosis. Would people with disabilities be better off under this? — The bill assists those with chronic conditions requiring dialysis through improved medical coverage.
- Healthcare
- Does this make health care easier to get in general? — The bill ensures coverage and separate payment for essential treatments for dialysis-related amyloidosis. Does this put more money into Medicare, the health coverage for people over 65? — The bill expands Medicare coverage to include specific treatments for dialysis-related amyloidosis.
- 9/18/2025
- 1 Cosponsor added.
- 7/14/2025
- 1 Cosponsor added.
- 6/20/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
Jerrold NadlerDemocrat · New York
David ValadaoRepublican · California